Arca Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABIO Nasdaq 8731 http://arcabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arca Biopharma Inc

ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review - May 5th, 2022 8:15 pm
ARCA biopharma Announces First Quarter 2022 Financial Results - May 2nd, 2022 8:15 pm
ARCA biopharma Establishes Special Committee of the Board of Directors - Apr 18th, 2022 8:30 pm
Albioma : Governance changes - Apr 5th, 2022 5:35 am
ARCA biopharma's Tissue Factor Inhibitor Disappoints In Mid-Stage COVID-19 Study - Apr 1st, 2022 11:09 am
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial - Mar 31st, 2022 8:15 pm
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update - Mar 14th, 2022 8:15 pm
Battalion Oil Corporation Announces Fourth Quarter and Full Year 2021 Financial and Operating Results - Mar 7th, 2022 9:30 pm
We're Keeping An Eye On ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate - Feb 8th, 2022 9:21 am
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2 - Jan 4th, 2022 1:30 pm
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19 - Dec 2nd, 2021 1:30 pm
ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past week - Nov 20th, 2021 12:01 pm
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th - Nov 9th, 2021 9:15 pm
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update - Nov 2nd, 2021 8:15 pm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - Oct 29th, 2021 11:03 am
ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged - Oct 29th, 2021 10:26 am
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety Data - Oct 28th, 2021 8:30 pm
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 - Sep 16th, 2021 12:30 pm
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th - Aug 16th, 2021 12:05 pm
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth - Aug 12th, 2021 5:15 am